- Home
- RVMD vs SUI Comparison
RVMD vs SUI Comparison
Compare RVMD & SUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RVMD | SUI |
|---|---|---|
| Founded | 2014 | 1975 |
| Country | United States | United States |
| Employees | 883 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.2B | 15.6B |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | RVMD | SUI |
|---|---|---|
| Price | $146.92 | $125.40 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 19 | 14 |
| Target Price | $140.84 | ★ $141.21 |
| AVG Volume (30 Days) | ★ 3.7M | 680.8K |
| Earning Date | 05-06-2026 | 04-27-2026 |
| Dividend Yield | N/A | ★ 3.54% |
| EPS Growth | N/A | ★ 1426.76 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,306,100,000.00 |
| Revenue This Year | N/A | $5.24 |
| Revenue Next Year | $533.02 | $5.08 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $34.00 | $115.53 |
| 52 Week High | $155.70 | $137.85 |
Technical Indicators
Market Signals| Indicator | RVMD | SUI |
|---|---|---|
| Relative Strength Index (RSI) | 63.54 | 39.13 |
| Support Level | $93.39 | $124.34 |
| Resistance Level | $152.85 | $128.46 |
| Average True Range (ATR) | 7.19 | 2.51 |
| MACD | -0.47 | -0.33 |
| Stochastic Oscillator | 61.79 | 23.60 |
Price Performance
Historical ComparisonAbout RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.
About SUI Sun Communities Inc.
Sun Communities is a residential REIT that focuses on owning manufactured housing and residential vehicle communities. The company currently owns a portfolio of 513 properties, which includes 347 manufactured housing communities and 166 residential vehicle communities. Sun targets owning properties that are desirable as second homes or vacation properties, with nearly 50% of the portfolio located in either Florida or Michigan near major bodies of water.